Jump to section
To accelerate R&D for scientists on the most promising new therapeutics.
There is said to be a revolution happening for AI extending into the science sector to help, more than anything, improve the speed of research and development. This is some of the most transformative and impactful work in the industry, with the idea that MedTech research could be sped up and step projects closer to finding cures is really exciting.
Biodock is a company founded by two Stanford students bringing their scientific expertise together with deep AI to form this platform. With a compute execution and results dashboard to help scientist customers run and interpret analysis quickly, the bioanalysis all runs through the cloud, accelerating R&D on new therapeutics.
The prospect for Biodock is very exciting, and multiple rounds of funding being secured since founding in 2020 is a sign of its promise. The company also appeared on Y Combinator Winter start-up list in 2021, gaining a boost in reputation. It’ll be interesting to see how Biodock develops further products and initiatives to continue on its mission.
Freddie
Company Specialist at Welcome to the Jungle
Michael Lee
(CEO)Studying Computer Science at Stanford University, before moving straight to founding Biodock.
Nurlybek Mursaliyev
(Co-founder)Presently completing a PhD at Stanford University in Stem Cell Biology and Regenerative Medicine. Prior to this, co-founded Smartlens.